Prognostic factors of second-line chemotherapy in advanced non-small cell lung cancer

PD were reviewed in this retrospective study. Age, gender, primary diseases, procedure, preoperative (PrO-) BMI, PrO-PNI and PrO-GNRI were examined. Postoperative 1 month (PoO1-) BMI, PoO1-PNI and PoO1-GNRI were also calculated after a month of primary operation in all cases. In 8 cases that survived more than one year without recurrence, these indexes were also calculated (PoO12-BMI, PoO12PNI and PoO12-GNRI). Results: Nine male and 2 female patients with mean age 71.1 were included in this study. The mean PrO-BMI, PrO-PNI and PrOGNRI were 22.5, 44.7 and 94.6, respectively. After one month from primary operation, PoO1-BMI, PoO1-PNI and PoO1-GNRI were 20.5, 41.1 and 86.0, respectively. In patients that survived more than one year without recurrence, PoO12-BMI, PoO12-PNI and PoO12-GNRI were 21.0, 54.7 and 102.1, respectively. Image